NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF
· Real-Time Price · USD
1.89
-0.03 (-1.56%)
At close: Aug 15, 2025, 3:59 PM
1.86
-1.59%
After-hours: Aug 15, 2025, 07:47 PM EDT
NewGenIvf Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2021 | Q2 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Dec 31, 2022 | Sep 30, 2021 | May 31, 2021 |
Cash & Equivalents | 457.74K | 169.66K | 54.1K | 38.75K | 121.57K | 54.72K | n/a | n/a |
Short-Term Investments | n/a | n/a | 11.88K | 39.25M | 38.48M | n/a | n/a | n/a |
Long-Term Investments | 204K | 6.05K | 21.26M | n/a | n/a | 70.69M | n/a | n/a |
Other Long-Term Assets | 33.33K | n/a | -19.67M | n/a | n/a | -506.34K | 210.19K | 64K |
Receivables | 1.36M | 354.1K | 519.55K | n/a | 898.3K | 2.32M | n/a | n/a |
Inventory | 80.81K | 238.86K | 126.26K | n/a | 68.05K | 46.91K | n/a | n/a |
Other Current Assets | 1.07M | n/a | 373.68K | n/a | 37.63M | -2.33M | 35.02K | 75.75K |
Total Current Assets | 3.17M | 977.56K | 2.46M | 39.34M | 38.67M | 91.73K | 35.02K | 75.75K |
Property-Plant & Equipment | 371.67K | 486.36K | 446K | n/a | 406K | 506.34K | n/a | n/a |
Goodwill & Intangibles | n/a | 2.7K | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 609K | 495.11K | 2.03M | n/a | 406K | 70.69M | 210.19K | 64K |
Total Assets | 3.78M | 1.47M | 4.49M | 39.34M | 38.67M | 70.79M | 245.21K | 139.75K |
Account Payables | 1.3M | 2.07M | 172.63K | n/a | 152.32K | 104.65K | n/a | n/a |
Deferred Revenue | 63.49K | 8.4K | 7.94K | n/a | 109.27K | 1.36M | n/a | n/a |
Short-Term Debt | 690.97K | 213.55K | n/a | 1.42M | n/a | n/a | 196.74K | 102.76K |
Other Current Liabilities | 554.38K | 688.68K | n/a | 3.01M | 2.55M | -2.51M | 25.56K | 14K |
Total Current Liabilities | 2.72M | 3.49M | 1.12M | 4.43M | 3.89M | 50K | 222.3K | 116.76K |
Long-Term Debt | 2.33M | 4.93M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | 3.36M | n/a | n/a | 2.17M | n/a | n/a |
Total Long-Term Liabilities | 2.34M | 5.06M | 3.48M | n/a | 157.02K | 2.42M | n/a | n/a |
Total Liabilities | 5.06M | 8.55M | 1.24M | 4.43M | 3.89M | 2.46M | 222.3K | 116.76K |
Total Debt | 3.03M | 5.27M | 332.55K | 1.42M | 353.06K | 452.04K | 196.74K | 102.76K |
Common Stock | n/a | n/a | 21.27M | 39.25M | 38.48M | 67.34M | 25K | 25K |
Retained Earnings | -985.99K | -8M | -5.67M | -4.35M | -899.44K | -591.54K | -2.09K | -2.01K |
Comprehensive Income | 18.88K | 3.37K | -7.29K | n/a | 37.78K | 9.57K | n/a | n/a |
Shareholders Equity | -844.61K | -6.58M | 15.6M | 34.91M | 34.78M | 68.32M | 22.91K | 22.99K |
Total Investments | 204K | 6.05K | 21.27M | 39.25M | 38.48M | 70.69M | n/a | n/a |